Brca-mutated Ovarian Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2018-02-07
Clinical Trial Update: Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy [Phase 3]
A Phase 3 trial evaluating olaparib as maintenance therapy in BRCA-mutated, platinum-sensitive ovarian cancer patients who achieved complete…